Efficacy and safety of sodium-glucose cotransporter-2 inhibitors for heart failure with mildly reduced or preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials

By sjmartinez • October 30, 2023

Cheema HA, Shafiee A, Athar MMT, Rafiei MA, Mehmannavaz A, Jafarabady K, Shahid A, Ahmad A, Ijaz SH, Dani SS, Minhas AMK, Nashwan AJ, Fudim M, Fonarow GC. Efficacy and safety of sodium-glucose cotransporter-2 inhibitors for heart failure with mildly reduced or preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials. Front Cardiovasc Med. 2023 Oct 12;10:1273781. doi: 10.3389/fcvm.2023.1273781. PMID: 37900570; PMCID: PMC10602781.

Tags: Cardiology/Epi, dapagliflozin, empagliflozin, heart failure, HFPEF, Publications, SGLT2I

Low-Dose Cardiac Radiation Improves Electrical Function and Reduces Ventricular Arrhythmogenesis in Mice With Nonischemic Cardiomyopathy

Abhyankar DA, Pennino MR, Pedersen LN, Grogan F, Klass A, Valenzuela Ripoll C, Ng S, Guo Z, Hajirezaei H, Rentschler SL, Robinson CG, Cuculich PS,[...]

Quadruple therapy in HFpEF with type 2 diabetes: Time to implement?

Fonarow GC, Keykhaei M. Quadruple therapy in HFpEF with type 2 diabetes: Time to implement? Kardiol Pol. 2025 Dec 18. doi: 10.33963/v.phj.110268. Epub ahead of[...]

The Effect of Urban Heat Island Intensity on the Rate of Emergency Department Visits for Acute Myocardial Infarctions

Lilley B, Amubieya O, Ziaeian B. The Effect of Urban Heat Island Intensity on the Rate of Emergency Department Visits for Acute Myocardial Infarctions. Eur[...]